News & Updates

Dabigatran as good as aspirin for recurrent stroke prevention in East Asian patients

05 Mar 2021

In preventing recurrent stroke in patients with embolic stroke of undetermined source (ESUS), dabigatran and aspirin are both useful, with the former showing no apparent superiority over the latter, according to data from the RE-SPECT ESUS* trial.

Dabigatran as good as aspirin for recurrent stroke prevention in East Asian patients

05 Mar 2021

Denosumab may reduce need for revision hip arthroplasty due to osteolysis

04 Mar 2021 by

Results of a small phase II, single-centre study have suggested that denosumab may be able to reduce the number of osteolysis-induced revision total hip arthroplasty surgeries.

Denosumab may reduce need for revision hip arthroplasty due to osteolysis

04 Mar 2021

CheckMate 274: Adjuvant nivolumab ups DFS in high-risk bladder cancer

04 Mar 2021 by

Treatment with the PD-1 immune checkpoint inhibitor nivolumab after radical surgery significantly extends disease-free survival (DFS) compared with placebo in patients with muscle-invasive urothelial carcinoma (MIUC) at high risk of recurrence, regardless of their PD-L1 status, according to the CheckMate 274 study presented at the 2021 ASCO GUCS.

CheckMate 274: Adjuvant nivolumab ups DFS in high-risk bladder cancer

04 Mar 2021

Nivolumab+cabozantinib demonstrates durable efficacy for renal cancer

04 Mar 2021 by

In the extended follow-up of the phase III CheckMate 9ER trial, nivolumab + cabozantinib (NIVO+CABO) continued to fare better than sunitinib for the treatment of advanced renal cell carcinoma (aRCC), regardless of sarcomatoid (sRCC) status.

Nivolumab+cabozantinib demonstrates durable efficacy for renal cancer

04 Mar 2021

Artesunate drip shows therapeutic benefit in severe malaria

04 Mar 2021

Patients with severe imported malaria appear to fare well with intravenous artesunate, despite an increased incidence of mild-to-moderate post-treatment delayed haemolysis, as reported in a study.

Artesunate drip shows therapeutic benefit in severe malaria

04 Mar 2021

Final TITAN results highlight apalutamide-ADT efficacy on survival in mCSPC

03 Mar 2021 by

Final analysis of the phase III TITAN* trial, presented at ASCO GU 2021, has shown that the addition of apalutamide to androgen deprivation therapy (ADT) improves overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC).

Final TITAN results highlight apalutamide-ADT efficacy on survival in mCSPC

03 Mar 2021

Antihypertensives use tied to thinner average retinal nerve fibre layer

03 Mar 2021

Use of two or more antihypertensive medications, angiotensin-converting enzyme inhibitor (ACEI), and diuretics appears to induce a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population, suggests a study.

Antihypertensives use tied to thinner average retinal nerve fibre layer

03 Mar 2021

Severe asthma patients on biologics predisposed to severe COVID-19

03 Mar 2021

Patients with severe asthma receiving treatment with biologics are more likely to contract COVID-19 and develop a severe course as compared with the general population, a study has found.

Severe asthma patients on biologics predisposed to severe COVID-19

03 Mar 2021

Solriamfetol offers hope for excessive daytime sleepiness in OSA

03 Mar 2021

The dopamine-norepinephrine reuptake inhibitor solriamfetol helps reduce excessive daytime sleepiness in patients with obstructive sleep apnoea (OSA), without compromising primary OSA treatment, as shown in a study.

Solriamfetol offers hope for excessive daytime sleepiness in OSA

03 Mar 2021

ActRII blockade a novel pharmacologic approach for weight loss?

03 Mar 2021 by

ActRII* pathway inhibition with bimagrumab led to weight loss and metabolic improvements in overweight/obese individuals with type 2 diabetes, a phase II trial suggests.

ActRII blockade a novel pharmacologic approach for weight loss?

03 Mar 2021

News & Updates

Filter by Specialty:

Specialty:

Dabigatran as good as aspirin for recurrent stroke prevention in East Asian patients

Dabigatran as good as aspirin for recurrent stroke prevention in East Asian patients

Denosumab may reduce need for revision hip arthroplasty due to osteolysis

Denosumab may reduce need for revision hip arthroplasty due to osteolysis

CheckMate 274: Adjuvant nivolumab ups DFS in high-risk bladder cancer

CheckMate 274: Adjuvant nivolumab ups DFS in high-risk bladder cancer

Nivolumab+cabozantinib demonstrates durable efficacy for renal cancer

Nivolumab+cabozantinib demonstrates durable efficacy for renal cancer

Artesunate drip shows therapeutic benefit in severe malaria

Artesunate drip shows therapeutic benefit in severe malaria

Final TITAN results highlight apalutamide-ADT efficacy on survival in mCSPC

Final TITAN results highlight apalutamide-ADT efficacy on survival in mCSPC

Antihypertensives use tied to thinner average retinal nerve fibre layer

Antihypertensives use tied to thinner average retinal nerve fibre layer

Severe asthma patients on biologics predisposed to severe COVID-19

Severe asthma patients on biologics predisposed to severe COVID-19

Solriamfetol offers hope for excessive daytime sleepiness in OSA

Solriamfetol offers hope for excessive daytime sleepiness in OSA

ActRII blockade a novel pharmacologic approach for weight loss?

ActRII blockade a novel pharmacologic approach for weight loss?